Hypophysitis, or inflammation of the pituitary gland, is one of the most common ICPi-related endocrinopathies and is mainly associated with anti-CTLA-4 therapy, but can also be encountered with PD1 and PDL-1 or combination therapies. This evidence concerns the gene CTLA4 and hypophysitis.